View Author

Sissmann, J.

( J. Sissmann)


van den meiracker effect hypertension receptor antagonist group irbesartan renin plasma treatment study value angiotensin 1 receptor antagonist placebo ang ii 100- mg dose 100- treatment groups article change patient 24- hour hemodynamic 25- meiracker 25- mg dose 100- mg doses blood concentration diastolic bp values 1 receptor blockade period losartan 24 hours 1- mg dose ang i antihypertensive effect response diastolic antihypertensive 24- baseline values window baseline heart systolic blockade aldosterone administration blood pressure heart rate order article angiotensin ii table measurement 5 ml blood plasma renin concentration randomization renin-angiotensin system method increase study day 100 mg j hypertens sodium inhibitor system pressure circle placebo group plasma norepinephrine sodium excretion timmermans pbmwm bp-lowering effect renin-angiotensin renin concentration result compound single-blind




1 Most Recent Publications

Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension (Article)
Admiraal, P.J.J. Janssen, J.A.M.J.L. Kroodsma, J.M. Ronde, W.A. de Boomsma, F. Sissmann, J. Blankestijn, P.J. Mulder, P.G.H. Man in 't Veld, A.J. Meiracker, A.H. van den
1995-01-01